Loading…
Combination of retrograde superselective intra-arterial chemotherapy and Seldinger method in locally advanced oral cancer
The nonsurgical strategies for locally advanced oral cancer are desirable. Superselective intra-arterial infusion with radiotherapy was utilized for this purpose, and there are two types of superselective intra-arterial infusion methods: The Seldinger method and the retrograde superselective intra-a...
Saved in:
Published in: | Journal of cancer research and therapeutics 2015-04, Vol.11 (2), p.475-478 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | 478 |
container_issue | 2 |
container_start_page | 475 |
container_title | Journal of cancer research and therapeutics |
container_volume | 11 |
creator | Uehara, Masataka Ohya, Ryouichi Kodama, Masaaki Shiraishi, Takeshi Asahina, Izumi Tominaga, Kazuhiro |
description | The nonsurgical strategies for locally advanced oral cancer are desirable. Superselective intra-arterial infusion with radiotherapy was utilized for this purpose, and there are two types of superselective intra-arterial infusion methods: The Seldinger method and the retrograde superselective intra-arterial chemotherapy (HFT method). In one case, the HFT method was applied to locally advanced tongue cancer, and the Seldinger method was used for additional administration of cisplatin (CDDP) to compensate for a lack of drug flow in the HFT method. In another case, the HFT method was applied to locally advanced lower gingival cancer. The Seldinger method was applied to metastatic lymph nodes. In both cases, additional administration of CDDP using the Seldinger method resulted in a complete response. The combination of the HFT and Seldinger methods was useful to eradicate locally advanced oral cancer because each method compensated for the defects of the other. |
doi_str_mv | 10.4103/0973-1482.140833 |
format | article |
fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_1694961615</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A421598531</galeid><sourcerecordid>A421598531</sourcerecordid><originalsourceid>FETCH-LOGICAL-c427t-1845b481332c0424d93219a35cb7e3a725061eaff51efa88c1666d10d29729723</originalsourceid><addsrcrecordid>eNptkk2LHCEQhiUkZCeb3HMKQi659MSvtvW4DJsPWMghyVkcrZ5xsXWiPQvz72Mzmw0Jg4JS9byFVr0IvaVkLSjhH4keeEeFYmsqiOL8GVpRrVUnKFfP0eopfYVe1XpPSD8wpl6iKyZbVDK2QqdNnrYh2TnkhPOIC8wl74r1gOvxAKVCBDeHB8AhzcV2tsxQgo3Y7WHK8x6KPZywTR5_h-hD2kHBE8z77JsAx-xsjC3vH2xy4HEui3S5l9foxWhjhTeP5zX6-en2x-ZLd_ft89fNzV3nBBvmjirRb4WinDNHBBNec0a15b3bDsDtwHoiKdhx7CmMVilHpZSeEs_0sGx-jT6c6x5K_nWEOpspVAcx2gT5WA2VWmhJJe0b-v4_9D4fS2qvWygple4J-UvtbAQT0phbY9xS1NwIRnutek4b1V2gdpBax2JOMIYW_odfX-Db8jAFd1FAzgJXcq0FRnMoYbLlZCgxizvMMn6zjN-c3dEk7x7_d9xO4J8Ef-zAfwN17rLe</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1696689500</pqid></control><display><type>article</type><title>Combination of retrograde superselective intra-arterial chemotherapy and Seldinger method in locally advanced oral cancer</title><source>Publicly Available Content Database</source><source>IngentaConnect Journals</source><creator>Uehara, Masataka ; Ohya, Ryouichi ; Kodama, Masaaki ; Shiraishi, Takeshi ; Asahina, Izumi ; Tominaga, Kazuhiro</creator><creatorcontrib>Uehara, Masataka ; Ohya, Ryouichi ; Kodama, Masaaki ; Shiraishi, Takeshi ; Asahina, Izumi ; Tominaga, Kazuhiro</creatorcontrib><description>The nonsurgical strategies for locally advanced oral cancer are desirable. Superselective intra-arterial infusion with radiotherapy was utilized for this purpose, and there are two types of superselective intra-arterial infusion methods: The Seldinger method and the retrograde superselective intra-arterial chemotherapy (HFT method). In one case, the HFT method was applied to locally advanced tongue cancer, and the Seldinger method was used for additional administration of cisplatin (CDDP) to compensate for a lack of drug flow in the HFT method. In another case, the HFT method was applied to locally advanced lower gingival cancer. The Seldinger method was applied to metastatic lymph nodes. In both cases, additional administration of CDDP using the Seldinger method resulted in a complete response. The combination of the HFT and Seldinger methods was useful to eradicate locally advanced oral cancer because each method compensated for the defects of the other.</description><identifier>ISSN: 0973-1482</identifier><identifier>EISSN: 1998-4138</identifier><identifier>DOI: 10.4103/0973-1482.140833</identifier><identifier>PMID: 26148622</identifier><language>eng</language><publisher>India: Medknow Publications and Media Pvt. Ltd</publisher><subject>Aged ; Analysis ; Antineoplastic Agents - administration & dosage ; Carcinoma, Squamous Cell - drug therapy ; Carcinoma, Squamous Cell - radiotherapy ; Catheters ; Chemotherapy ; Chemotherapy, Adjuvant - methods ; Cisplatin - administration & dosage ; Drug therapy ; Female ; Health aspects ; Humans ; Infusions, Intra-Arterial - methods ; Lymph Nodes - drug effects ; Lymph Nodes - radiation effects ; Lymphatic Metastasis - radiotherapy ; Lymphatic system ; Methods ; Middle Aged ; Mouth cancer ; Mouth Neoplasms - drug therapy ; Mouth Neoplasms - radiotherapy ; Veins & arteries</subject><ispartof>Journal of cancer research and therapeutics, 2015-04, Vol.11 (2), p.475-478</ispartof><rights>COPYRIGHT 2015 Medknow Publications and Media Pvt. Ltd.</rights><rights>Copyright Medknow Publications & Media Pvt Ltd Apr-Jun 2015</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/1696689500?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,25752,27923,27924,37011,37012,44589</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26148622$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Uehara, Masataka</creatorcontrib><creatorcontrib>Ohya, Ryouichi</creatorcontrib><creatorcontrib>Kodama, Masaaki</creatorcontrib><creatorcontrib>Shiraishi, Takeshi</creatorcontrib><creatorcontrib>Asahina, Izumi</creatorcontrib><creatorcontrib>Tominaga, Kazuhiro</creatorcontrib><title>Combination of retrograde superselective intra-arterial chemotherapy and Seldinger method in locally advanced oral cancer</title><title>Journal of cancer research and therapeutics</title><addtitle>J Cancer Res Ther</addtitle><description>The nonsurgical strategies for locally advanced oral cancer are desirable. Superselective intra-arterial infusion with radiotherapy was utilized for this purpose, and there are two types of superselective intra-arterial infusion methods: The Seldinger method and the retrograde superselective intra-arterial chemotherapy (HFT method). In one case, the HFT method was applied to locally advanced tongue cancer, and the Seldinger method was used for additional administration of cisplatin (CDDP) to compensate for a lack of drug flow in the HFT method. In another case, the HFT method was applied to locally advanced lower gingival cancer. The Seldinger method was applied to metastatic lymph nodes. In both cases, additional administration of CDDP using the Seldinger method resulted in a complete response. The combination of the HFT and Seldinger methods was useful to eradicate locally advanced oral cancer because each method compensated for the defects of the other.</description><subject>Aged</subject><subject>Analysis</subject><subject>Antineoplastic Agents - administration & dosage</subject><subject>Carcinoma, Squamous Cell - drug therapy</subject><subject>Carcinoma, Squamous Cell - radiotherapy</subject><subject>Catheters</subject><subject>Chemotherapy</subject><subject>Chemotherapy, Adjuvant - methods</subject><subject>Cisplatin - administration & dosage</subject><subject>Drug therapy</subject><subject>Female</subject><subject>Health aspects</subject><subject>Humans</subject><subject>Infusions, Intra-Arterial - methods</subject><subject>Lymph Nodes - drug effects</subject><subject>Lymph Nodes - radiation effects</subject><subject>Lymphatic Metastasis - radiotherapy</subject><subject>Lymphatic system</subject><subject>Methods</subject><subject>Middle Aged</subject><subject>Mouth cancer</subject><subject>Mouth Neoplasms - drug therapy</subject><subject>Mouth Neoplasms - radiotherapy</subject><subject>Veins & arteries</subject><issn>0973-1482</issn><issn>1998-4138</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNptkk2LHCEQhiUkZCeb3HMKQi659MSvtvW4DJsPWMghyVkcrZ5xsXWiPQvz72Mzmw0Jg4JS9byFVr0IvaVkLSjhH4keeEeFYmsqiOL8GVpRrVUnKFfP0eopfYVe1XpPSD8wpl6iKyZbVDK2QqdNnrYh2TnkhPOIC8wl74r1gOvxAKVCBDeHB8AhzcV2tsxQgo3Y7WHK8x6KPZywTR5_h-hD2kHBE8z77JsAx-xsjC3vH2xy4HEui3S5l9foxWhjhTeP5zX6-en2x-ZLd_ft89fNzV3nBBvmjirRb4WinDNHBBNec0a15b3bDsDtwHoiKdhx7CmMVilHpZSeEs_0sGx-jT6c6x5K_nWEOpspVAcx2gT5WA2VWmhJJe0b-v4_9D4fS2qvWygple4J-UvtbAQT0phbY9xS1NwIRnutek4b1V2gdpBax2JOMIYW_odfX-Db8jAFd1FAzgJXcq0FRnMoYbLlZCgxizvMMn6zjN-c3dEk7x7_d9xO4J8Ef-zAfwN17rLe</recordid><startdate>20150401</startdate><enddate>20150401</enddate><creator>Uehara, Masataka</creator><creator>Ohya, Ryouichi</creator><creator>Kodama, Masaaki</creator><creator>Shiraishi, Takeshi</creator><creator>Asahina, Izumi</creator><creator>Tominaga, Kazuhiro</creator><general>Medknow Publications and Media Pvt. Ltd</general><general>Medknow Publications & Media Pvt. Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20150401</creationdate><title>Combination of retrograde superselective intra-arterial chemotherapy and Seldinger method in locally advanced oral cancer</title><author>Uehara, Masataka ; Ohya, Ryouichi ; Kodama, Masaaki ; Shiraishi, Takeshi ; Asahina, Izumi ; Tominaga, Kazuhiro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c427t-1845b481332c0424d93219a35cb7e3a725061eaff51efa88c1666d10d29729723</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Aged</topic><topic>Analysis</topic><topic>Antineoplastic Agents - administration & dosage</topic><topic>Carcinoma, Squamous Cell - drug therapy</topic><topic>Carcinoma, Squamous Cell - radiotherapy</topic><topic>Catheters</topic><topic>Chemotherapy</topic><topic>Chemotherapy, Adjuvant - methods</topic><topic>Cisplatin - administration & dosage</topic><topic>Drug therapy</topic><topic>Female</topic><topic>Health aspects</topic><topic>Humans</topic><topic>Infusions, Intra-Arterial - methods</topic><topic>Lymph Nodes - drug effects</topic><topic>Lymph Nodes - radiation effects</topic><topic>Lymphatic Metastasis - radiotherapy</topic><topic>Lymphatic system</topic><topic>Methods</topic><topic>Middle Aged</topic><topic>Mouth cancer</topic><topic>Mouth Neoplasms - drug therapy</topic><topic>Mouth Neoplasms - radiotherapy</topic><topic>Veins & arteries</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Uehara, Masataka</creatorcontrib><creatorcontrib>Ohya, Ryouichi</creatorcontrib><creatorcontrib>Kodama, Masaaki</creatorcontrib><creatorcontrib>Shiraishi, Takeshi</creatorcontrib><creatorcontrib>Asahina, Izumi</creatorcontrib><creatorcontrib>Tominaga, Kazuhiro</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of cancer research and therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Uehara, Masataka</au><au>Ohya, Ryouichi</au><au>Kodama, Masaaki</au><au>Shiraishi, Takeshi</au><au>Asahina, Izumi</au><au>Tominaga, Kazuhiro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Combination of retrograde superselective intra-arterial chemotherapy and Seldinger method in locally advanced oral cancer</atitle><jtitle>Journal of cancer research and therapeutics</jtitle><addtitle>J Cancer Res Ther</addtitle><date>2015-04-01</date><risdate>2015</risdate><volume>11</volume><issue>2</issue><spage>475</spage><epage>478</epage><pages>475-478</pages><issn>0973-1482</issn><eissn>1998-4138</eissn><abstract>The nonsurgical strategies for locally advanced oral cancer are desirable. Superselective intra-arterial infusion with radiotherapy was utilized for this purpose, and there are two types of superselective intra-arterial infusion methods: The Seldinger method and the retrograde superselective intra-arterial chemotherapy (HFT method). In one case, the HFT method was applied to locally advanced tongue cancer, and the Seldinger method was used for additional administration of cisplatin (CDDP) to compensate for a lack of drug flow in the HFT method. In another case, the HFT method was applied to locally advanced lower gingival cancer. The Seldinger method was applied to metastatic lymph nodes. In both cases, additional administration of CDDP using the Seldinger method resulted in a complete response. The combination of the HFT and Seldinger methods was useful to eradicate locally advanced oral cancer because each method compensated for the defects of the other.</abstract><cop>India</cop><pub>Medknow Publications and Media Pvt. Ltd</pub><pmid>26148622</pmid><doi>10.4103/0973-1482.140833</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0973-1482 |
ispartof | Journal of cancer research and therapeutics, 2015-04, Vol.11 (2), p.475-478 |
issn | 0973-1482 1998-4138 |
language | eng |
recordid | cdi_proquest_miscellaneous_1694961615 |
source | Publicly Available Content Database; IngentaConnect Journals |
subjects | Aged Analysis Antineoplastic Agents - administration & dosage Carcinoma, Squamous Cell - drug therapy Carcinoma, Squamous Cell - radiotherapy Catheters Chemotherapy Chemotherapy, Adjuvant - methods Cisplatin - administration & dosage Drug therapy Female Health aspects Humans Infusions, Intra-Arterial - methods Lymph Nodes - drug effects Lymph Nodes - radiation effects Lymphatic Metastasis - radiotherapy Lymphatic system Methods Middle Aged Mouth cancer Mouth Neoplasms - drug therapy Mouth Neoplasms - radiotherapy Veins & arteries |
title | Combination of retrograde superselective intra-arterial chemotherapy and Seldinger method in locally advanced oral cancer |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T07%3A42%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Combination%20of%20retrograde%20superselective%20intra-arterial%20chemotherapy%20and%20Seldinger%20method%20in%20locally%20advanced%20oral%20cancer&rft.jtitle=Journal%20of%20cancer%20research%20and%20therapeutics&rft.au=Uehara,%20Masataka&rft.date=2015-04-01&rft.volume=11&rft.issue=2&rft.spage=475&rft.epage=478&rft.pages=475-478&rft.issn=0973-1482&rft.eissn=1998-4138&rft_id=info:doi/10.4103/0973-1482.140833&rft_dat=%3Cgale_proqu%3EA421598531%3C/gale_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c427t-1845b481332c0424d93219a35cb7e3a725061eaff51efa88c1666d10d29729723%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1696689500&rft_id=info:pmid/26148622&rft_galeid=A421598531&rfr_iscdi=true |